This message contains images. If you don't see images, click here to view.
Advertise in this news brief.

Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    

Replace Messy Ice Baths

Cool to -60C. Heat to +150C. Designed for laboratory use, TECA cold/hot plates offer convenient thermal control of samples in histology and life sciences applications.



Meet the candidates — 2014 NSH board of directors election
Every two years, The NSH Nominations-Election Committee conducts an election for the board of directors which include the positions of president, vice president, secretary, treasurer and nine region directors. Elected officers are responsible for overseeing the goals and upholding the mission of the Society. Members will have an opportunity to vote for all officer positions and the region director for the region in which they reside. The committee has solicited candidates and the following ballot will be presented in April. View 2014-2016 candidates here.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Histotechnology Professionals Day — March 10
With less than a week away, are you ready for your big celebration? NSH has been sending out orders throughout the past few weeks, and cannot believe the day is almost here. Place an order for last minute items here. We also want to remind all NSH Members to keep an eye out for scavenger hunt and free webinar information next week! For Histotechnology Professionals Day updates become a fan of the Facebook page and use the official hashtag #histoday. We want to see what fun activities you have planned for your Monday.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Study: Medical research still lags on women
The Boston Globe
Glaring gaps persist in medical researchers' efforts to understand gender differences in common diseases, two decades after the passage of pivotal legislation mandating that more women be included in government-funded clinical trials, according to a report recently released at a women's health summit in Boston. The authors said research still lags on understanding how treatments for heart disease — the number one killer of women — affect the sexes differently, because women make up only one-third of the participants in clinical trials to test drugs and medical devices, and most of these studies don't report results for men and women separately.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Space Station discoveries lead to less toxic targeted cancer treatments
BioNews Texas
Invasive and systemic treatments are a sometimes necessary evil for treating advanced and/or aggressive cancers, but they mean patients must endure devastating side effects including nausea, immune suppression, hair loss and even organ failure as an unwanted result of in the effort to combat cancerous tissues in the body. Consequently, treatments that primarily or exclusively target a patient's cancerous tissues could provide clinicians with an alternative methodology of fighting the malignancy, and reduce or eliminate administration of toxic levels of chemotherapy drugs and/or radiation, substantially improving quality of life for patients. And according to NASA scientists, research that began in space may soon result in such options becoming available.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

FDA speeds innovation in rare disease therapies
U.S. Food and Drug Administration
Patients often need advocates, and that can be especially true for people with a rare disease, who have unique problems and may have little or no support or available treatment. The Food and Drug Administration is committed to helping patients and advancing rare disease therapies through the development of "orphan" medical products, including drugs, biologics (such as a protein, vaccine or blood product), and devices used to treat a rare disease or condition. The Orphan Drug Act defines a disease as rare if fewer than 200,000 people in the United States have it.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

  Reduce Cost with Same Quality

GBI Labs produces the largest selection of secondary detection kits. We provide free samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market. Some 110mL kits cost as little as $700.00 and 18 ml kit > $300.00.

Nuclear stiffness keeps stem cells and cancer cells in place
Bioscience Technology
Adult stem cells and cancer cells have many things in common, including an ability to migrate through tiny gaps in tissue. Both types of cells also experience a trade off when it comes to this ability; having a flexible nucleus makes migration easier but is worse at protecting the nucleus' DNA compared to a stiffer nucleus. Nuclear proteins that regulate nuclear stiffness are therefore thought to control processes as diverse as tissue repair and tumor growth.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

A complete medical checkup on a chip
R&D Magazine
About the size of a stapler, this new handheld device developed at EFPL in Switzerland is able to test a large number of proteins in our body all at once — a subtle combination of optical science and engineering.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Empowering Science with Color Integrity

Datacolor CHROMACAL™ standardizes color reproduction in digital brightfield images.

• Delivers a consistent, reliable basis for evaluation, communication, quantification, documentation and publication
• Includes image and monitor calibration software, along with a proprietary color calibration slide
• Integrates into existing imaging workflow
• Compatible with most microscopes, scientific cameras and acquisition software

ergoCentric Laboratory Seating

Visit LabStorage System’s updated website to view details about this new laboratory seating with specially formulated Infection Control coating. Non-porous and easily disinfected, this moisture proof coating is anti-bacterial, anti-fungal and stain resistant. more

To find out how to feature your company in Under the Microscope and other advertising opportunities, Contact Geoffrey Forneret at 469.420.2629

More info


Study identifies key protein that helps prevent lung cancer tumors from being destroyed
Translational Genomics Research Institute via Medical Xpress
Researchers at the Translational Genomics Research Institute have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and drug treatments. Non-small cell lung cancer makes up about 85 percent of the nearly 160,000 Americans expected to die this year from lung cancer, which by far kills more patients than any other type of cancer; accounting for more than 1 in 4 cancer deaths in the U.S. annually. The five-year survival rate for advanced NSCLC is less than 10 percent.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
Looking for similar articles? Search here, keyword RESEARCH.

Learning to lead a lab
Firing a member of your lab is difficult. Fortunately, it's also rare. The first and only time cell biologist Samara Reck-Peterson had to do it, in her laboratory at Harvard University, she felt prepared. She had practiced the difficult conversation during a lab management course she'd taken in 2009, and she had a script ready. "Practicing is really the most important thing," she says. It helped her anticipate which parts of the conversation were likely to trigger emotional responses so she could head them off in the real conversation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Sugars may act as mirrors into cancer cells
Carbohydrate molecules may serve as signals for cancer, pointing to new ways in which sugars can be used to look at the inner workings of cells. "Carbohydrates can tell us a lot about what's going on inside of a cell, so they are potentially good markers for disease," says Lara Mahal, an associate professor in New York University's Department of Chemistry and the study's corresponding author. "Our study reveals how cancer cells produce certain 'carbohydrate signatures' that we can now identify."
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Breast cancer spread may be reduced by silencing a gene
Medical News Today
Myoferlin, a protein only recently linked to cancer, may help breast cancer cells transform so they can escape tumors and migrate to new sites. When researchers implanted mice with breast cancer cells that couldn't make the protein because its gene was switched off, the cells did not transform into the type that migrates. Researchers at The Ohio State University in Columbus, Ohio, had already shown this was happening in cell cultures. Now in a study published in the journal PLOS ONE, they describe how they got similar results in mice.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Is pharmaceutical biotech investment at risk?
Mike Wokasch
High profitability, strong cash positions, large global healthcare market opportunities, reliable dividends, and perceived security and stability have provided Big Pharma Biotech investors a solid basis for investment rationale. On the other hand, increasing cost of R & D, prolonged time to market, pricing pressures, marketing constraints, and regulatory uncertainty and challenges are now eroding investor confidence and interest.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Missed last week's issue? See which articles your colleagues read most.

    Tiny motors that fit inside human cells could someday treat disease (Gigaom)
Making the Case for Case Study Presentations in the Histology Laboratory or Histotech Program (NSH)
Rare disease in women pulls together community of researchers and patients (Medical Xpress)

Don't be left behind. Click here to see what else you missed.

Under the Microscope
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642   
Contribute news

This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063